ARTICLE | Financial News
6 Dimensions leads Lyvgen's $30M series B
July 16, 2018 10:56 PM UTC
Lyvgen Biopharma Co. Ltd. (Shanghai, China) raised $30 million in a series B round led by 6 Dimensions Capital. New investors Winfair Global and Runling Capital and existing investor Morningside Ventures also participated.
Lyvgen is developing immuno-oncology candidates using its crosslink antibody platform which activates specific receptors in the tumor microenvironment while reducing immune-mediated adverse effects in healthy tissue...
BCIQ Company Profiles
BCIQ Target Profiles